Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00176423
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: galantamine

Indicates status has not been verified in more than two years